Human trials of second Russian COVID-19 vaccine to start July 27 - TASS
- Country:
- Russian Federation
Human trials of Russia's second potential coronavirus vaccine, developed by the Siberian Vector institute, will begin on July 27, the TASS news agency cited Russia's consumer safety watchdog as saying on Friday.
An early-stage human trial of a separate vaccine, developed by the Gamaleya institute in Moscow, was completed this month, with scientists hailing the results and authorities planning to move to mass production in the autumn.
ALSO READ
-
Inside Russia’s SMR School, Where Nuclear Experience Shapes Future Energy Decisions
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
Russia’s Reach Beyond Borders Leaves Exiled Critics Living in Fear, UN Expert Warns
-
Ukraine Faces Another Bitter Winter as UN Inquiry Warns of Deepening Civilian Harm
-
Ukraine War: UN Documents 1,004 Sexual Violence Cases and Calls for Justice
Google News